**: Pharmacy manager.
HUAWEI CLOUD has entered the offline pharmacy market and has reached a comprehensive cooperation with Liu Pharmaceutical Group and Runda Medical.
Huawei began to empower pharmacies
Recently, Guangxi Liu Pharmaceutical Group issued a document saying that the company has fully cooperated with Huawei Cloud and Runda Medical, and has carried out in-depth cooperation in chain smart pharmacies, smart hospitals, and smart medical cloud. This also means that Huawei has extended its health-related business to offline pharmacies.
It is reported that the cooperation between HUAWEI CLOUD, Liu Pharmaceutical Group, and Runda Medical will empower pharmacies through the "Smart Medical Cloud", and apply AI scenarios such as smart inspection, smart follow-up, smart patient education, and digital human health education to provide value-added services such as auxiliary analysis of test reports, digital escort recuperation, and personalized health management for end customers of pharmacies.
This tripartite cooperation will promote the effective connection of Liu Pharmaceutical Group's Internet hospitals, prescription sharing, and physical pharmacy services, realize the integrated intelligent management of the whole course from preventive diagnosis and treatment to drug use, help improve the diagnosis and treatment effect and the level of residents' independent health management, and form a one-stop "medicine + medicine + health management" full life cycle service closed loop.
In terms of AI, HUAWEI CLOUD provides full-stack and all-scenario AI solutions, including AI platforms, AI marketplaces, AI applications, and AI services, supporting full-process AI development from data preprocessing, model training, model inference, and model management, to facilitate the digital transformation of various industries, including offline pharmacies.
Not only for pharmacies, but also for the pharmaceutical industry, HUAWEI CLOUD's AI business has already been applied to the pharmaceutical field.
For example, the HUAWEI CLOUD AI Model (Pangu Model) is a drug molecular model based on deep Xi to help researchers quickly discover and optimize new drug candidates.
For the 1.7 billion drug molecules on the market, the AI model can be pre-trained on their chemical structures, and the structural reconstruction rate, legality, uniqueness and other indicators are better than the existing methods in the chemical unsupervised Xi mode.
In addition, the AI model generated 100 million innovative drug-like small molecule screening libraries with a structural novelty of 9968%, which can effectively generate new compounds with similar physical and chemical properties, creating the possibility of discovering new drugs.
With the development of big data and informatization, and the promotion and application of AI models, the pharmaceutical industry has ushered in an era of digital transformation.
Through the application of HUAWEI CLOUD's computing power support and AI capabilities based on the Pangu Medical Model and Runda Medical's "Good Doctor Xiaohui", the three parties will deeply explore the value of massive high-quality medical literature and medical big data such as diseases, drug maps, first-class solutions, and test reports, so as to realize the auxiliary analysis of patients' medical consultations, examination reports, clinical diagnoses, and medical records, and effectively support medical testing, smart hospitals, and AI application in Internet hospital scenarios.
In the past 10 years, Huawei has invested nearly one trillion yuan in R&D
It is worth mentioning that after the release of Huawei's mobile phone Mate60 Pro, its localized 7nm mobile phone SoC (Kirin 9000S) broke the West's "encirclement and blockade" of domestic high-end chip manufacturing, which has attracted widespread attention at home and around the world, and Huawei's brand image and influence have risen sharply again.
In addition,As a typical representative of high-tech enterprises in China, Huawei has achieved leading positions in many fields, such as communication manufacturing, chip design, artificial intelligence, cloud computing, big data, Internet of Things, smart terminals (including mobile phones), underlying software frameworks, and electric vehicle technology (including intelligent driving).
In 2022, Huawei's global revenue was 642.3 billion yuan and its net profit was 35.6 billion yuanR&D investment was 161.5 billion yuan, accounting for more than 25% of the annual revenue. In the past decade, Huawei has invested more than 977.3 billion yuan in R&D.
It should be noted that Huawei has been sanctioned by the United States and other countries since 2019, and the company's revenue has not yet recovered to its historical peak level (in 2019, Huawei's total revenue was 858.8 billion yuan).
Willow medicine "Guizhong Pharmacy."Ranked 12th in the country.
According to official information, Liu Pharmaceutical Group is a comprehensive listed pharmaceutical company, with an operating income of 190 in 20225.3 billion yuan, currently ranked 16th in the ranking of the top 100 pharmaceutical wholesale enterprises in the country's main business income.
Founded in September 2001, Guizhong Pharmacy Chain, a subsidiary of Liu Pharmaceutical Group, ranked 12th in the "Top 100 Pharmaceutical Retail Enterprises in China in terms of Total Sales".The company's sales scale exceeded 3.1 billion yuan, and now it has 801 pharmacies, covering 14 prefecture-level cities and more than 40 counties in Guangxi.
Runda Medical, founded in 1999, as a comprehensive medical laboratory service provider, has more than 40 wholly-owned or holding subsidiaries across the country and overseas, covering most of the provinces, cities and regions in the country, and the products it provides cover the main segments of the in vitro diagnostic industry (IVD, In-Vitro Diagnostics).
At present, Runda Medical has developed into one of the leading enterprises in product circulation and comprehensive services in the domestic IVD industry. It is understood that with the help of its own comprehensive service system, the company provides comprehensive services of in vitro diagnostic products and professional technical support to various medical laboratories.